[IHH] QoQ TTM Result on 30-Sep-2018 [#3]

Stock
[IHH] IHH HEALTHCARE BERHAD
Announcement Date
27-Nov-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Sep-2018 [#3]
Profit Trend
QoQ- -45.89%
YoY- -73.43%
Quarter Report
Latest QR
Upcoming QR
IHH's Result
IHH's Financial Summary
View:
Show?
TTM Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 13,294,285 12,308,666 11,520,932 11,240,717 11,200,657 11,312,767 11,142,639 12.52%
PBT 948,897 849,678 752,470 41,989 487,117 728,233 1,164,453 -12.78%
Tax -399,700 -397,911 -262,610 -225,470 -273,369 -313,549 -334,625 12.61%
NP 549,197 451,767 489,860 -183,481 213,748 414,684 829,828 -24.11%
-
NP to SH 679,850 659,962 627,687 219,525 405,687 557,142 969,953 -21.14%
-
Tax Rate 42.12% 46.83% 34.90% 536.97% 56.12% 43.06% 28.74% -
Total Cost 12,745,088 11,856,899 11,031,072 11,424,198 10,986,909 10,898,083 10,312,811 15.20%
-
Net Worth 22,191,750 21,923,241 21,152,362 21,353,811 21,182,083 21,340,529 21,916,086 0.83%
Dividend
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Div 252,817 252,817 252,817 247,173 247,173 247,173 247,173 1.52%
Div Payout % 37.19% 38.31% 40.28% 112.59% 60.93% 44.36% 25.48% -
Equity
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Net Worth 22,191,750 21,923,241 21,152,362 21,353,811 21,182,083 21,340,529 21,916,086 0.83%
NOSH 8,773,990 8,769,296 8,769,296 8,244,803 8,244,590 8,239,596 8,239,109 4.29%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 4.13% 3.67% 4.25% -1.63% 1.91% 3.67% 7.45% -
ROE 3.06% 3.01% 2.97% 1.03% 1.92% 2.61% 4.43% -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
RPS 151.56 140.36 136.71 136.34 135.90 137.30 135.24 7.91%
EPS 7.75 7.53 7.45 2.66 4.92 6.76 11.77 -24.37%
DPS 2.88 2.88 3.00 3.00 3.00 3.00 3.00 -2.69%
NAPS 2.53 2.50 2.51 2.59 2.57 2.59 2.66 -3.29%
Adjusted Per Share Value based on latest NOSH - 8,244,803
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
RPS 150.85 139.67 130.73 127.55 127.09 128.37 126.43 12.53%
EPS 7.71 7.49 7.12 2.49 4.60 6.32 11.01 -21.19%
DPS 2.87 2.87 2.87 2.80 2.80 2.80 2.80 1.66%
NAPS 2.5181 2.4876 2.4001 2.423 2.4035 2.4215 2.4868 0.83%
Price Multiplier on Financial Quarter End Date
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Date 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 -
Price 5.80 5.77 5.39 5.21 6.10 6.05 5.86 -
P/RPS 3.83 4.11 3.94 3.82 4.49 4.41 4.33 -7.87%
P/EPS 74.83 76.67 72.37 195.67 123.93 89.47 49.78 31.32%
EY 1.34 1.30 1.38 0.51 0.81 1.12 2.01 -23.74%
DY 0.50 0.50 0.56 0.58 0.49 0.50 0.51 -1.31%
P/NAPS 2.29 2.31 2.15 2.01 2.37 2.34 2.20 2.71%
Price Multiplier on Announcement Date
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Date 30/08/19 30/05/19 27/02/19 27/11/18 28/08/18 25/05/18 27/02/18 -
Price 5.79 5.48 5.66 4.92 5.63 6.26 6.11 -
P/RPS 3.82 3.90 4.14 3.61 4.14 4.56 4.52 -10.63%
P/EPS 74.70 72.82 75.99 184.78 114.38 92.58 51.90 27.56%
EY 1.34 1.37 1.32 0.54 0.87 1.08 1.93 -21.64%
DY 0.50 0.53 0.53 0.61 0.53 0.48 0.49 1.35%
P/NAPS 2.29 2.19 2.25 1.90 2.19 2.42 2.30 -0.29%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment